Conference Description
The 2021 Gordon Research Conference (GRC) on Alcohol-Induced End Organ Diseases will provide a unique forum to bring together a diverse range of young and established scientists who are studying alcohol-related organ damage. This Gordon Research Conference exclusively addresses alcohol-induced end organ disorders and will cover a broad range of studies at the molecular, cellular, systems and organismal level, with particular emphasis on translational and therapeutic approaches.
This GRC will 1) provide an international forum that promotes open discussion of cutting edge research at the forefront of alcohol-induced tissue injury, 2) foster the development of the next generation of investigators to study alcohol-induced organ damage, 3) promote interaction between young and senior investigators, 4) facilitate the exchange of ideas that will shape the future directions of the alcohol and tissue injury community and 5) introduce breakthrough techniques that facilitate the understanding of mechanisms driving alcohol-induced tissue injury. This conference will address questions centered on the basic mechanisms that contribute to alcohol-induced organ damage, translational studies and therapeutic opportunities for patients with alcohol-associated organ damage.
The format will provide ample time for formal and informal discussions and emphasize the presentation of unpublished data, thus ensuring that the newest and most exciting developments in the field are discussed. Poster presentations will take place on each day of the meeting, allowing for widespread participation of conference attendees at all career stages. Speakers will also be selected from submitted abstracts for "late-breaking topic" talks by young investigators. Participation by young investigators will be strongly encouraged.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by June 24, 2021. Please check back for updates.
Keynote Session: Forward Genetics of Fatty Liver Disease
Discussion Leaders
-
Hidekazu Tsukamoto (University of Southern California, USA)
Speakers
-
Bruce Beutler (University of Texas Southwestern Medical Center, USA)
-
Zhao Zhang (University of Texas Southwestern Medical Center, USA)
Alcohol and the Metabolic Syndrome
Discussion Leaders
-
Mark Czaja (Emory University, USA)
Speakers
-
Rotonya Carr (University of Pennsylvania, USA)
-
Laura Nagy (Liver Disease Research Center, Cleveland Clinic Lerner Research Institute, USA)
-
Z. Gordon Jiang (Beth Israel Deaconess Medical Center / Harvard Medical School, USA)
-
Caroline Morel (Beth Israel Deaconess Medical Center, Harvard University, USA)
Alcohol and Lifespan
Discussion Leaders
-
Patricia Molina (LSU Health Sciences Center New Orleans, USA)
Speakers
-
Ramon Bataller (University of Pittsburgh, USA)
-
Wen-Xing Ding (University of Kansas Medical Center, USA)
Microbiome and Intestine-Derived Molecules
Discussion Leaders
-
Craig McClain (University of Louisville, USA)
Speakers
-
Jing Yuan (Capital Institute of Pediatrics, China)
-
Jasmohan Bajaj (Virginia Commonwealth University Health, USA)
-
Cristina Llorente (University of California, San Diego, USA)
-
Je-Hyun Yoon (Medical University of South Carolina, USA)
Immunity and Infections: Implications for Diseases Associated with Alcohol
Discussion Leaders
-
Pranoti Mandrekar (University of Massachusetts Medical School, USA)
Speakers
-
Shilpa Chokshi (King's College London, United Kingdom)
-
Rebecca McCullough (University of Colorado Denver, USA)
-
Derrick Samuelson (University of Nebraska, USA)
Alcohol-Mediated Changes in Organ Metabolism
Discussion Leaders
-
Shelly Lu (Cedars-Sinai Medical Center, USA)
Speakers
-
Bin Gao (National Institutes of Health, USA)
-
Erin Lowery (Loyola University Chicago, USA)
-
David Mangelsdorf (University of Texas Southwestern Medical Center / Howard Hughes Medical Institute, USA)
-
Pal Pacher (National Institute on Alcohol Abuse and Alcoholism, NIH, USA)
Cancer Stem Cells and Alcohol-Associated Cancer
Discussion Leaders
-
Anna Mae Diehl (Duke University Medical Center, USA)
Speakers
-
Yin Cao (Washington University in St. Louis, USA)
-
Jürgen Rehm (University of Toronto, Canada)
-
Keigo Machida (Keck School of Medicine, University of Southern California, USA)
Discovery of Mechanism-Based Biomarkers
Discussion Leaders
-
Vijay Shah (Mayo Clinic, USA)
Speakers
-
Aleksander Krag (University of Southern Denmark, Denmark)
-
Harmeet Malhi (Mayo Clinic, USA)
-
Steven Weinman (University of Kansas Medical Center, USA)
-
Suthat Liangpunsakul (Indiana University School of Medicine, USA)
Therapeutic Concepts for Alcohol-Associated Organ Diseases
Discussion Leaders
-
Suthat Liangpunsakul (Indiana University School of Medicine, USA)
Speakers
-
Kun Cheng (University of Missouri, USA)
-
Mack Mitchell (University of Texas Southwestern Medical Center, USA)
-
Holger Willenbring (University of California, San Francisco, USA)
